News and Announcements
Sovereign-Backed Investment Firm Seeking Companies Looking to IPO on the Hong Kong Growth Enterprise Markets
- Published March 13, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
A sovereign-backed investment firm specialising in IPO and expansion into China and ASEAN, is looking for private companies generating at least AUD2mil in net profits, to invest and IPO on the Hong Kong Growth Enterprise Markets.
- Technology, Media and Telecommunications (TMT)
- Ecommerce
- Food & Beverage (F&B)
- Fast Moving Consumer Goods (FMCG)
- Financial Services
- Manufacturing
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
